Stille

Stille Retained Earnings

The Retained Earnings of Stille (STIL.ST) as of Oct 29, 2026 is 202.82 M SEK. In the previous year, Retained Earnings was 147.12 M SEK — a change of 37.86% (higher).

Retained Earnings

202.82 MSEK

YoY

37.86%

Last updated:

Retained Earnings of Stille is 2025 202.82 M SEK. Retained Earnings of Stille was 2024 147.12 M SEK. It decreases by 37.86% higher compared to the previous year.

The Stille Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
17.01 M SEK
Jan 1, 2019
32.82 M SEK
Jan 1, 2020
41.09 M SEK
Jan 1, 2021
48.98 M SEK
Jan 1, 2022
71.30 M SEK
Jan 1, 2023
88.92 M SEK
Jan 1, 2024
147.12 M SEK
Jan 1, 2025
202.82 M SEK
The Stille Retained Earnings history
YEARRetained EarningsYoY
202.82 MSEK+37.86%
147.12 MSEK+65.46%
88.92 MSEK+24.72%
71.30 MSEK+45.55%
48.98 MSEK+19.20%
41.09 MSEK+25.21%
32.82 MSEK+92.94%
17.01 MSEK+653.37%
2.26 MSEK-130.10%
-7.50 MSEK-64.01%
-20.84 MSEK-33.74%
-31.45 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Retained Earnings of Stille is 202.82 M SEK in 2025.

Retained Earnings of Stille changed from 147.12 M SEK to 202.82 M SEK, representing a 37.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Stille since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Stille historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Stille

All Key Metrics — Stille